EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF
Authors:
Open Access
- 23 March 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (12) , 9766-9780
Abstract
EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGFKeywords
This publication has 32 references indexed in Scilit:
- Targeting Extracellular Domains D4 and D7 of Vascular Endothelial Growth Factor Receptor 2 Reveals Allosteric Receptor Regulatory SitesMolecular and Cellular Biology, 2012
- EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2PLOS ONE, 2010
- EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2α–mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2Blood, 2009
- CD147 Impacts Angiogenesis and Metastasis FormationCancer Investigation, 2009
- Extracellular Matrix Metalloproteinase Inducer Up-regulates the Urokinase-Type Plasminogen Activator System Promoting Tumor Cell InvasionCancer Research, 2007
- Extracellular Matrix Metalloproteinase Inducer Stimulates Tumor Angiogenesis by Elevating Vascular Endothelial Cell Growth Factor and Matrix MetalloproteinasesCancer Research, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003
- Mapping of the Sites Involved in Ligand Association and Dissociation at the Extracellular Domain of the Kinase Insert Domain-containing Receptor for Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1998
- Mapping of the Sites for Ligand Binding and Receptor Dimerization at the Extracellular Domain of the Vascular Endothelial Growth Factor Receptor FLT-1Journal of Biological Chemistry, 1997